FDA Ruling Shakes Up Biotech: Gilead, AbbVie And More

By: via Benzinga
Biotechs have had a tough week. On Wednesday, stocks plummeted after Citron Research released a new report classifying Valeant ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.